Public data does not show enough current analyst targets to build a reliable consensus for GFAI. The sole attributed figure is the $4.50 call from Jesse Sobelson at D. Boral Capital, last updated in April 2025. Other scattered values appear to be data artifacts. In the absence of fresh consensus, the $1.00 level comes directly from Nasdaq Listing Rule 5550(a)(2). The company received a deficiency notice in December 2025 and secured an extension through December 7, 2026, to close at or above $1.00 for 10 straight business days or face delisting.
At the most recent close, GFAI changed hands near $0.18 within a 52-week range of roughly $0.175 to $1.02. Closing the gap to $1.00 would mean an advance of approximately 450%. Fundamentals show trailing revenue around $35 million against a net loss near $5 million, a negative P/E ratio, and a market cap of about $6 million. Thin liquidity and a small share count keep volatility elevated, yet volatility alone does not generate sustainable value. A durable recovery would likely need a reverse split, improved earnings, or a clear strategic catalyst.
Several developments might help. The company has indicated it may pursue a reverse stock split to address the deficiency. It has also authorized a $5 million share repurchase program and completed the MGAI acquisition to broaden its healthcare AI offerings. Any return to profitability, steadier revenue, or renewed interest in automation and robotics could lift sentiment. Regaining Nasdaq compliance would remove a significant overhang and potentially draw in investors who avoid sub-$1.00 names.
Challenges remain considerable. The firm continues to post losses and negative earnings per share, with delisting risk if it cannot sustain the $1.00 bid. A reverse split would lift the nominal price without altering underlying economics, and such actions in small caps often encounter renewed selling. Low trading volume and a modest market cap amplify downside moves. Additional pressures, including a pullback in speculative AI stocks or softer demand for logistics and robotics services, could weigh on the shares. A recent downgrade from Weiss Ratings in October 2026 reflects the cautious outlook.
The chart shows GFAI well below its 50-day moving average near $0.30 and its 200-day moving average near $0.43, and far under the $1.02 52-week high. The $1.00 mark serves as both a psychological barrier and the critical regulatory threshold, acting as major resistance. On the downside, the recent low around $0.175 stands as key support; a break below it would deepen the decline and complicate compliance efforts without corporate action.
Because the $1.00 objective is regulatory rather than an analyst forecast, the relevant deadline is the December 7, 2026 compliance window disclosed by the company. I’m watching upcoming earnings releases, any reverse-split or buyback announcements, shifts in cash position and losses, and formal Nasdaq updates. Developments in the AI and robotics segment, along with broader sentiment toward small-cap and automation names, will also matter. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
In my own analysis, Tickeron’s AI Daily Buy/Sell Signals provide a helpful way to monitor thousands of stocks and ETFs with AI-driven Buy, Sell, or Hold signals based on technical and market shifts. For a low-priced, volatile name like GFAI, these tools can help identify potential turning points and track trend changes more efficiently than manual review alone, complementing fundamental work on compliance and operations.
Reaching $1.00 for Guardforce AI is ultimately a question of corporate action and listing survival as much as fundamental improvement. The level is the Nasdaq minimum bid threshold the company has publicly committed to addressing, possibly through a reverse split. The required move of roughly 450% from current levels is substantial, and ongoing losses, thin liquidity, and delisting risk remain serious hurdles. A reverse split or genuine operational turnaround could lift the price to $1.00, but such steps would not by themselves confirm fundamental health. Investors should track earnings, cash position, compliance announcements, and AI-segment momentum before forming conclusions, and no outcome is assured.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
It is expected that a price bounce should occur soon.
The Moving Average Convergence Divergence (MACD) for GFAI just turned positive on October 28, 2026. Looking at past instances where GFAI's MACD turned positive, the stock continued to rise in 31 of 40 cases over the following month. The odds of a continued upward trend are 77%.
Following a +3.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where GFAI advanced for three days, in 143 of 184 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
GFAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GFAI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for GFAI entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.187) is normal, around the industry mean (2.993). P/E Ratio (-0.630) is within average values for comparable stocks, (2.637). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.749). Dividend Yield (0.000) settles around the average of (0.297) among similar stocks. GFAI's P/S Ratio (0.205) is slightly lower than the industry average of (2.085).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. GFAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GFAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry MiscellaneousCommercialServices